Orgentec Diagnostics

Orgentec Diagnostics

Mainz, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Orgentec Diagnostika is a well-established, revenue-generating diagnostics company with a 35+ year history in autoimmune and infectious disease testing. Its core business revolves around the Alegria® automated ELISA platform and associated test kits and reagents. As part of the Sebia Group since its acquisition, Orgentec benefits from enhanced commercial scale and resources while navigating integration and a competitive, innovation-driven market.

Autoimmune DiseasesInfectious Diseases

Technology Platform

Alegria® automated random-access ELISA and immunofluorescence platform utilizing proprietary SMC® (Strip Module Carrier) technology for monotest, walk-away automation.

Opportunities

Leveraging Sebia's global commercial network to expand into new geographic markets.
Potential for integrated workflow solutions combining Orgentec's autoimmune testing with Sebia's electrophoresis portfolio, offering a compelling value proposition to clinical laboratories.

Risk Factors

Operational and cultural integration risks following the acquisition by Sebia.
Intense competition in the automated diagnostics sector from larger, well-capitalized companies risks technological obsolescence.

Competitive Landscape

Competes in the specialized autoimmune diagnostics segment against companies like Werfen (INOVA), Thermo Fisher (Phadia), Euroimmun, and Bio-Rad. The broader market for laboratory automation is dominated by large IVD players such as Roche, Abbott, Siemens Healthineers, and Beckman Coulter.